SLC16A13 and type 2 diabetes mellitus: Our work proposes SLC16A13 gain-of-function genetic variants to increase T2D risk and raises the question about a potential causative role for SLC16A13 other than SLC16A11, highlighting the need of additional studies to better understand the distinct mechanism through which these SLC16 transporters affect the development of T2D.